Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MMP-9 dependent extracellular protein changes in the left ventriclar infarcts at day 7 post myocardial infarction

ABSTRACT: Glycopeptides of the LVI tissues of WT and MMP-9 null mice at day-7 post-MI.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart

DISEASE(S): Cardiovascular System Disease

SUBMITTER: Yuan Tian

LAB HEAD: Merry Lindsey

PROVIDER: PXD001393 | Pride | 2018-03-06

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	050213_Yuan_1.msf	Msf
	050213_Yuan_1.pep.xml	Pepxml
	050213_Yuan_1.raw	Raw
	050213_Yuan_10.msf	Msf
	050213_Yuan_10.pep.xml	Pepxml

Items per page:

1 - 5 of 51

Publications

CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling.

DeLeon-Pennell Kristine Y KY Tian Yuan Y Zhang Bai B Cates Courtney A CA Iyer Rugmani Padmanabhan RP Cannon Presley P Shah Punit P Aiyetan Paul P Halade Ganesh V GV Ma Yonggang Y Flynn Elizabeth E Zhang Zhen Z Jin Yu-Fang YF Zhang Hui H Lindsey Merry L ML

Circulation. Cardiovascular genetics 20151117 1

<h4>Background</h4>After myocardial infarction, the left ventricle undergoes a wound healing response that includes the robust infiltration of neutrophils and macrophages to facilitate removal of dead myocytes as well as turnover of the extracellular matrix. Matrix metalloproteinase (MMP)-9 is a key enzyme that regulates post-myocardial infarction left ventricular remodeling.<h4>Methods and results</h4>Infarct regions from wild-type and MMP-9 null mice (n=8 per group) analyzed by glycoproteomics ...[more]

PMID: 26578544

Similar Datasets

Project description:The plasma of the sepsis patient survivors and non-survivors (n=10/group) were analyzed using glycoproteomics approach.

2018-10-19 | PXD001425 | Pride

Project Grandiose, cell surface protein capture

Project description:The aim of Project Grandiose has been to examine the process of somatic cell (specifically, murine fibroblast) conversion to induced pluripotent stem cells, at many levels (proteome, mRNA, DNA methylation, etc.), over the time course of the conversion. This dataset represents the cell surface proteome portion of the project, namely the set of cell surface glycoproteins that were detected over theproject time course.

2014-11-27 | PXD001456 | Pride

Comparative analysis of the human and mouse placental transcriptome and proteome

Project description:An important question for the use of the mouse as a model for studying human disease is the degree of functional conservation of genetic control pathways from human to mouse. The human and mouse placenta show structural similarities but there have been no systematic attempt to assess their molecular similarities or differences. We built a comprehensive database of protein and microarray data for the highly vascular exchange region micro-dissected from the human and mouse placenta near-term. Abnormalities in this region are associated with two of the most common and serious complications of human pregnancy, maternal preeclampsia (PE) and fetal intrauterine growth restriction (IUGR), each disorder affecting ~5% of all pregnancies. Over 7,000 orthologs were detected with 70% co-expressed and over 80% of genes known to cause placental phenotypes in mouse were co-expressed. These genes form a tight protein-protein interaction network with novel candidate genes likely to be important in placental structure and/or function. The entire data is available as a web-accessible database to guide the informed development of mouse models to study human disease This experiment is now fully represented in NCBI Peptidome database with accession PSE115; http://www.ncbi.nlm.nih.gov/peptidome/search/index.shtml?acc=PSE115 Microdissection of human villous trees and mouse placental labyrinth. Tissues were split for microarray and protein analysis. For protein analysis samples were first fractionated by differential sucrose gradients into mitochrondria, cytosol, microsomes and nuclei. Mitochrondira and neuclei were each extracted by two different methods for soluble and insoluble material. Each subcellular fraction for each tissue was analysed in quintuplet by 9 step 2 dimensional LC/MSMS. This generated a total of 270 mzXML files for each tissue.

2009-06-29 | E-GEOD-13299 | biostudies-arrayexpress

QToF Cross-linking Optimisation

Project description:Optimising the parameters for cross-link analysis using a QToF mass spectrometer. We performed triplicate analysis of 6 different collision energy ramps to determine the optimal energy for cross-link fragmentation.

2019-11-12 | PXD011704 | Pride

Detection of Five Solid Carcinomas Using Blood Circulating Proteins

Project description:When diagnosed in a metastatic stage cancer is mostly incurable making its early detection via biomarkers of immense clinical interest. Proteins circulating in blood are a preferred source of biomarkers for a wide range of cancers due to the ease and non-invasiveness of collection. Our approach to cancer biomarker discovery is based on the observation that proteomic changes in tumor tissue are remotely detectable as changes in the protein composition of blood plasma. To determine whether these changes in the plasma of patients are specific for their specific cancer or represent a response to cancer in general we performed a cross-tumor plasma proteomic study. Using a proteomic serum/plasma workflow consisting of the combined use of N-glycosite enrichment and SWATH mass spectrometry (SWATH-MS), we investigated 155 blood samples derived from cohorts of patients with carcinomas at a localized or locally advanced clinical stage, or from a matched control group. A quantitative comparison of the resulting N-glycosite profiles indicated that some biomarkers are common to several cancers, while others are highly specific for one cancer type.

2018-08-09 | PXD004998 | Pride

Physiological and proteomic changes in soft wheat seeds during accelerated aging

Project description:Wheat (Triticum aestivum L.), one of the most important crops in the world, is a staple food used for making flour, noodles, alcoholic beverages, biofuel and a variety of other products. In wheat, kernel texture and biochemical composition vary with different hardnesses. Previous study of our research group indicated that physiological properties changes including germination ratio, and physiological enzymatic activities in wheat with different hardnesses were different. A comparative proteomic analysis of soft and hard wheat embryos by our research group identified more proteins associated with anti-resistance in soft wheat than that in hard wheat. Additionally, quantitative proteomic analysis of medium-hard wheat ‘Aikang58’ seeds showed that 162 differentially expressed proteins (DEPs) participated in metabolism, energy supply, and defense/stress responses were identified during artificial ageing were identified in our previous research. However, the dynamic physiological and quantitative proteomic changes in soft wheat seeds during accelerated aging remain unclear, thus need to be elucidated. In this work, we conducted the first Tandem Mass Tag (TMT)-based dynamic quantitative proteomic analysis of elite Chinese soft wheat cultivar ‘Yangmai 15’ seeds during artificial ageing. The uncovered differentially expressed proteins (DEPs) with different functions might provide new insights into the comprehensive understanding of deterioration in soft wheat seeds.

2018-10-08 | PXD009156 | Pride

ChIP-chip by array of human B-acute lymphoblastic leukaemia cells using AcH3, H3K4M3 and H3K27M3 antibodies

Project description:B-ALL Xenograft Histone Modification at BIM locus<br>The cells used are human B- acute lymphoblastic leukaemia cells that have been propagated in<br>NOD/SCID mice. B-ALL2 and B-ALL3 are cells from two different patients.<br><br>Normalized data files containing chromosome 2 data are available on the FTP site for this experiment in the E-MEXP-2814.additional.zip archive.

2011-06-14 | E-MEXP-2814 | biostudies-arrayexpress

Protein profiling and identification of new biomarkers of brain ischemia by MALDI-imaging-mass-spectrometry

Project description:Introduction The identification of proteins involved in brain ischemia might allow the discovery of new putative biomarkers or potential therapeutic target of one of the most important neurological disorders. MALDI Imaging-Mass-Spectrometry (IMS) is a powerful technique that allows the visualization of protein distribution along a tissue without labeling. Our aim is to study the distribution of proteins along mouse brain after an ischemic insult and to identify relevant proteins involved in brain ischemia. Materials and methods We occluded the middle cerebral artery (60min) of C57BL/6J mice (n=4) with 24h of reperfusion. Brain slices were analyzed by MALDI-TOF and mass spectra from infarct (IC) and contralateral (CL) regions were compared using ClinProTools. Relevant m/z were selected after PCA analysis and their ion distribution maps were analyzed by FlexImagin3.0. Protein identification was conducted on mouse brain homogenates through a bottom-up approach consisting on complementary fractionations based on tricine gels and RP-HPLC. The identifications were confirmed by immunohistochemistry. Results We identified 102 m/z with different abundances between IC and CL (p<0.05), from which 21 m/z were selected by PCA as more relevant. Thirteen of them were found increased in the infarct region and 4 m/z showed a discrimination higher than 90% between IC and CL. After bottom-up identification, immunohistochemistry analysis confirmed increased ATP5i and COX6C expressions, and decreased UMP-CMP kinase in IC compared to CL. Conclusions We identified for the first time by MALDI-IMS several m/z peaks with different abundances between IC and CL. These proteins involved in brain ischemia might represent potential diagnostic biomarkers or target molecules for neurological recovery.

2016-12-14 | PXD003644 | Pride

Glycoprotein Signatures for Aggressive Prostate Cancer via SWATH mass spectrometry

Project description:The identification of biomarkers indicating the level of aggressiveness of prostate cancer (PCa) addresses an urgent clinical need to minimize the general over-treatment of patients with non-aggressive PCa, which account for the majority of PCa cases. In this study we combined N-glycopeptide isolation and SWATH-MS towards the molecular characterization of tumor malignancy and aggressiveness. Here, we isolated formerly N-linked glycopeptides from normal prostate (n=10), non-aggressive (n=22), aggressive (n=16) and metastatic PCa (n=25) tumor tissues and analyzed the samples by SWATH-MS, an emerging data independent mass spectrometric acquisition method that generates a single MS file containing fragment ion spectra of all ionized species of a sample. The resulting datasets were searched using a targeted data analysis strategy where a priori spectral reference library representing known N-glycosites of the human proteome was used to identify groups of signals in the SWATH-MS data. On-average we identified 1430 N-glycosites from each SWATH map of which 1057 were quantified across all samples. The 220 glycoproteins that showed significant quantitative changes associated diverse biological processes with the level of PCa aggressiveness and metastasis and indicated functional relationships with common PCa genomic mutations.

2014-04-23 | PXD000704 | Pride

Characterization of signaling pathways associated with pancreatic beta-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db miceCharacterization of signaling pathways associated with pancreatic β-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db mice

Project description:To characterize the signaling mechanisms underlying beta-cell dysfunction in db/db mice and their return to a more “normal” beta-cell phenotype, we applied a mass spectrometry-based quantitative phosphophoproteomics and sialiomics(sialylated N-linked glycopeptides) approach to normal and db/db beta-cells from hyperglycemic and euglycemic environments.

2020-05-19 | PXD017469 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data